DXB Chart, page-1084

You need to get your head out of the sand...


$1 is around 550m valuation for a company with positive interim analysis and two deals signed ... with a TAM much much higher than NEU...

if you are not a sad sod and follow the whole discussion, I also referred to companies with 4bn valuations in 2021 with limited data but a promise...I called that excessive but also said valuations are worse in bio sector in last 2-3 years...

I also mentioned that money will come back to biotech later this as it was highly neglected due to higher interest rates ...

You obviously won't be satisfied...don't give a tuff

you must b a lot of fun at parties....

Hope u get a life... ciao.....